93 related articles for article (PubMed ID: 30481379)
1. Clinico-pathological features and survival of patients with malignant exocrine pancreatic neoplasms: The AC Camargo Cancer Center experience.
Fonseca de Jesus VH; Guedes Camandaroba MP; Spina Donadio MD; Cabral A; Pimentel Muniz T; de Moura Leite L; Ferreira Sant'Ana L; Luiz da Costa W; Curado MP; Coimbra FJF
J Surg Oncol; 2019 Jan; 119(1):71-78. PubMed ID: 30481379
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
[TBL] [Abstract][Full Text] [Related]
3. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
4. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
[TBL] [Abstract][Full Text] [Related]
7. Differences in survival by histologic type of pancreatic cancer.
Fesinmeyer MD; Austin MA; Li CI; De Roos AJ; Bowen DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1766-73. PubMed ID: 16030115
[TBL] [Abstract][Full Text] [Related]
8. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract][Full Text] [Related]
9. KDM4D Predicts Recurrence in Exocrine Pancreatic Cells of Resection Margins from Patients with Pancreatic Adenocarcinoma.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Anticancer Res; 2018 Apr; 38(4):2295-2302. PubMed ID: 29599352
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
11. The differential diagnosis of squamous cells in pancreatic aspirates: from contamination to adenosquamous carcinoma.
Olson MT; Siddiqui MT; Ali SZ
Acta Cytol; 2013; 57(2):139-46. PubMed ID: 23406837
[TBL] [Abstract][Full Text] [Related]
12. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
14. [Importance of surgical staging in patients with cancer of the exocrine pancreas].
Acea Nebril B; Taboada Filgueira L; Parajó Calvo A; Freire Rodríguez D; Fraguela Mariña J; Gómez Freijoso C
Rev Esp Enferm Dig; 1993 Jun; 83(6):447-52. PubMed ID: 8338709
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
[TBL] [Abstract][Full Text] [Related]
16. Is liver resection in metastases of exocrine pancreatic carcinoma justified?
Saif MW
JOP; 2011 Jan; 12(1):68-9; author reply 71. PubMed ID: 21206108
[No Abstract] [Full Text] [Related]
17. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.
Ravikumar R; Sabin C; Abu Hilal M; Bramhall S; White S; Wigmore S; Imber CJ; Fusai G;
J Am Coll Surg; 2014 Mar; 218(3):401-11. PubMed ID: 24484730
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma.
Brown EG; Canter RJ; Bold RJ
J Surg Oncol; 2015 Mar; 111(3):293-8. PubMed ID: 25330934
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
20. National failure to operate on early stage pancreatic cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS
Ann Surg; 2007 Aug; 246(2):173-80. PubMed ID: 17667493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
